Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

• Main Authors: Lim, E.H., Zhang, S.-L., Li, J.-L., Yap, W.-S., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M., Chang, A., Ng, A., Tan, P.
• Other Authors: STATISTICS & APPLIED PROBABILITY
• Format: Article
• Published: 2014
• Subjects: Advanced stage; CMET mutations; Early stage; EGFR mutations; KRAS mutations; Low-volume biopsies; Non-small cell lung cancer; P53 mutations; Prognosis; Whole genome amplification
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/105456
• Institution: National University of Singapore

Journal of Thoracic Oncology